Contact us at 914-666-4665

Dr. Daniel Cameron

Board-certified physician with 38+ years specializing in Lyme disease and tick-borne illnesses. Past President of ILADS (International Lyme and Associated Diseases Society) and first author of ILADS treatment guidelines. Dr. Cameron operates a solo practice focused on patient advocacy and evidence-based Lyme disease treatment. He is the author of 1,100+ articles spanning diagnosis, treatment, co-infections, and recovery from tick-borne illnesses. His work challenges conventional approaches that often leave patients undiagnosed or undertreated, emphasizing clinical judgment over rigid adherence to testing criteria that frequently produce false negatives.

Dr. Daniel Cameron
injured toddler with Lyme disease and bandaid on arm

Lyme disease symptoms in toddler attributed to child abuse

Lyme disease symptoms in toddler attributed to child abuse Welcome to another Inside Lyme Podcast. I am your host Dr. Daniel Cameron. In this episode, I will be discussing a case involving a toddler with Lyme disease whose symptoms were mistakenly attributed to child abuse. By Dr. Daniel Cameron   The case was first described

Lyme disease symptoms in toddler attributed to child abuse Read More »

man with lyme disease and arthritis rubbing his knee

Lyme disease protein tricks immune system, ignites arthritis

Lyme disease protein tricks immune system, ignites arthritis Lyme disease patients often struggle with ongoing symptoms including arthritis. Findings from this latest study are a “testament to how unique this bacterium is — and how we need to keep working to understand more about what is going on behind the scenes in order to develop

Lyme disease protein tricks immune system, ignites arthritis Read More »

babesia microti in MS patient

Babesia microti Infection in a Multiple Sclerosis Patient on Ocrevus

Babesia microti Infection in a Multiple Sclerosis Patient on Ocrevus Welcome to another Inside Lyme Podcast. I am your host Dr. Daniel Cameron. In this episode, I discuss the case of a 54-year-old man with a 12-year history of multiple sclerosis who was diagnosed with Babesia microti while receiving ocrelizumab (Ocrevus). By Dr. Daniel Cameron

Babesia microti Infection in a Multiple Sclerosis Patient on Ocrevus Read More »

facial palsy from lyme disease in elderly man

Patient with facial palsy from Lyme disease fails treatment

Patient with facial palsy from Lyme disease fails treatment In this case report, Hareem and colleagues describe a 71-year-old man with facial palsy from Lyme disease who failed treatment. The authors offer an inside look at what led up to the failed treatment.¹ Steroids associated with treatment failure? The man was initially treated in August

Patient with facial palsy from Lyme disease fails treatment Read More »

In for the Long Haul: Lyme & COVID-19

Long COVID and Lyme Disease Q&A | Project Lyme Webinar

Long COVID and Lyme Disease Q&A Sponsored by Project Lyme Long COVID and Lyme disease share many overlapping symptoms, including fatigue, brain fog, and autonomic dysfunction. In this webinar hosted by Project Lyme, Lyme disease expert Dr. Daniel Cameron joins integrative medicine physician Dr. Bill Rawls to discuss the similarities between Long COVID and chronic

Long COVID and Lyme Disease Q&A | Project Lyme Webinar Read More »

what does a lyme disease rash look like

What Does a Lyme Disease Rash Look Like? Symptoms and EM Rash Variations

What Does a Lyme Disease Rash Look Like? What does a Lyme disease rash look like? It is a question I am asked frequently in clinical practice. In this episode of the Inside Lyme Podcast, I discuss how the erythema migrans rash can appear differently depending on age, sex, duration of infection, and body location.

What Does a Lyme Disease Rash Look Like? Symptoms and EM Rash Variations Read More »

Rituximab and B-Cell Therapy Can Delay Lyme Disease Diagnosis

Rituximab and B-Cell Therapy Can Delay Lyme Disease Diagnosis B-cell suppressive therapies such as rituximab can delay Lyme disease diagnosis. These medications reduce the body’s ability to produce antibodies — the same antibodies that standard Lyme disease tests rely on to detect infection. As a result, patients receiving immune-modulating therapy may have false-negative or borderline

Rituximab and B-Cell Therapy Can Delay Lyme Disease Diagnosis Read More »